SCHEMBL17054103

SCHEMBL17054103

Cc1c2c(nc3ccc(C(C)(C)C)cc13)OC(C)CC2

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.37
▸ CYP1A2 P05177 3/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ TSHR P16473 2/20 0.37
▸ GRM2 Q14416 2/20 0.36
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ MAPT P10636 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ BCHE P06276 4/20 0.32
▸ ACHE P22303 4/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ SCN10A Q9Y5Y9 1/20 0.32
▸ PTGFR P43088 2/20 0.31
▸ ATM Q13315 1/20 0.31
▸ DHODH Q02127 1/20 0.31
▸ TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29661841 0.90 GRM2 (0.39) KDM4ECYP1A2ALDH1A1TSHRGRM2
SCHEMBL17054193 0.90 GRM2 (0.39) KDM4ECYP1A2ALDH1A1TSHRGRM2
SCHEMBL17054083 0.84 KDM4E (0.44) KDM4ECYP1A2ALDH1A1TSHRGRM2
SCHEMBL28773717 0.82 GRM2 (0.50) KDM4ECYP1A2ALDH1A1TSHRGRM2
SCHEMBL17054094 0.80 KDM4E (0.59) KDM4ECYP1A2ALDH1A1TSHRKMT2A
SCHEMBL17054196 0.80 CYP1A2 (0.37) KDM4ECYP1A2ALDH1A1TSHRGRM2
SCHEMBL29661864 0.80 CYP1A2 (0.37) KDM4ECYP1A2ALDH1A1TSHRGRM2
SCHEMBL29661821 0.80 KDM4E (0.59) KDM4ECYP1A2ALDH1A1TSHRKMT2A
SCHEMBL17054088 0.79 CYP1A2 (0.60) KDM4ECYP1A2ALDH1A1TSHRMEN1
SCHEMBL29661981 0.79 CYP1A2 (0.60) KDM4ECYP1A2ALDH1A1TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10696635-B2 Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates THE SCRIPPS RESEARCH INSTITUTE (US) 2020-06-30 — — US disclosed
US-10611723-B2 Ligand-enabled meta-C-H activation using a transient mediator THE SCRIPPS RESEARCH INSTITUTE (US) 2020-04-07 — — US disclosed
US-20190119212-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS THE SCRIPPS RESEARCH INSTITUTE 2019-04-25 — — US disclosed
WO-2017184589-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS THE SCRIPPS RESEARCH INSTITUTE (US) 2017-10-26 — — WO disclosed
WO-2016123361-A1 LIGAND-ENABLED META-C-H ACTIVATION USING A TRANSIENT MEDIATOR THE SCRIPPS RESEARCH INSTITUTE (US) 2016-08-04 — — WO disclosed
WO-2015131100-A1 LIGAND-CONTROLLED C(SP3)-H ARYLATION AND OLEFINATION IN SYNTHESIS OF UNNATURAL CHIRAL ALPHA AMINO ACIDS THE SCRIPPS RESEARCH INSTITUTE (US) 2015-09-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10611723-B2 Ligand-enabled meta-C-H activation using a transient mediator HRH4, AHR, HRH3 KDM4E 3368/4885CYP1A2 1268/4885ALDH1A1 2756/4885
US-20190119212-A1 A VERSATILE LIGAND FOR PALLADIUM-CATALYZED META-C-H FUNCTIONALIZATIONS AHR, PAH, DOHH KDM4E 3516/4885CYP1A2 28/4885ALDH1A1 208/4885
US-10696635-B2 Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates PAH, AHR, DDC KDM4E 3453/4885CYP1A2 15/4885ALDH1A1 121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback